Gregory G. Freitag


Mr. Freitag, J.D., CPA, joined Axogen, Inc. (formerly LecTec Corporation) in June 2010. Greg has been a member of its Board of Directors since September 2011 and Special Counsel since June 2020.  Mr. Freitag was General Counsel from September 2011 to June 2020, Senior Vice President Business Development from May 2014 to October 2018 and Chief Financial Officer from September 2011 to May 2014 and August 2015 to March 2016. He was chief executive officer, chief financial officer and a board member of LecTec Corporation, an IP licensing and holding company that merged with Axogen in September 2011, from June 2010 through September 2011. Since May 2009, Greg has been a principal of FreiMc, LLC, a consulting and advisory firm that provides strategic guidance and business development advisory services related to the life sciences and healthcare markets. Prior to founding FreiMc, LLC, Greg was the director of business development at Pfizer Health Solutions, a former subsidiary of Pfizer, Inc., from January 2006 to May 2009. From July 2005 to January 2006, Greg worked for Guidant Corporation in their business development group. Prior to Guidant Corporation, Greg was the chief executive officer of HTS Biosystems, a biotechnology tools start-up company, from March 2000 until its sale in early 2005. Greg was the chief operating officer, chief financial officer and general counsel of Quantech, Ltd., a public point-of-care diagnostic company, from December 1995 to March 2000. Prior to that time, Greg practiced corporate/securities law in Minneapolis, Minnesota. Greg is also a director of the Foundation Board of HealthEast Care System, a healthcare system in Minnesota, and PDS Biotechnology Corporation, a private, clinical stage biopharmaceutical company developing immunotherapies for cancer and other disease areas such as infectious disease.